The invention provides novel soluble conazole crystalline forms (e.g. itraconazole, posaconazole and saperconazole) that include salts, co-crystals and related solvates useful as pharmaceuticals. The invention also provides pharmaceutical compositions comprising, and processes for making, these conazole crystalline forms. Methods of using such compositions for the treatment or prevention of systemic and local fungal, yeast, and dermatophyte infections are also provided.
RELATED APPLICATIONS
This application claims priority to U.S. Provisional Patent Application No. 60/384,152 filed on May 31, 2002; U.S. Provisional Patent Application No. 60/439,282 filed on Jan. 10, 2003; U.S. Provisional Patent Application No. 60/444,315 filed on Jan. 31, 2003; and U.S. Provisional Patent Application No. 60/463,962 filed on Apr. 18, 2003, which are all hereby incorporated by reference for all purposes.
